Clinical trial NCT00680381: Transitional Treatment of Adolescents in Family Therapy
Official title: Transitional Treatment of Adolescents in Family Therapy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE1
Conditions: Substance Abuse
Keywords: adolescent substance abuse
Lead sponsor: Oregon Research Institute
Sponsor class: OTHER
First posted: 2008-05-20
Enrollment: 90
Sex: ALL
Minimum age (years): 13
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: FACTORIAL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.


Eligibility criteria: Inclusion Criteria:

1. At least one parent, step-parent, or surrogate parent willing to participate in the study
2. 13 to 18 years if age
3. meets DSM-IV (APA, 1994) diagnostic criteria for substance abuse or dependence
4. Lives in the Albuquerque metropolitan area or surrounding communities with a parent, step-parent, or surrogate parent; AND
5. Sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake).

Exclusion Criteria:

1. Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures
2. Adolescent deemed dangerous to self or others during evaluation
3. Services other than outpatient treatment required for the adolescent (e.g., inpatient, detoxification)
4. Adolescent already has participated in treatment project at CFAR; AND
5. A sibling is already participating in project.

Primary outcomes:
measure: Drug use levels for adolescents who have received family therapy and one of the three aftercare regimens
timeFrame: pretx and 6 wks, 4 , 7 and 12 mos. post initial therapy session
Secondary outcomes:
Other outcomes:
Locations:
city: Albuquerque
country: United States
facility: Oregon Res. Inst. Center for Family & Adolescent Research (CFAR)
state: New Mexico
Study officials:
affiliation: Oregon Research Institute Center for Family and Adolescent Research (ORI/CFAR)
name: Holly B. Waldron, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References: